- Home
- RYAM vs CDXC Comparison
RYAM vs CDXC Comparison
Compare RYAM & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYAM
- CDXC
- Stock Information
- Founded
- RYAM 1926
- CDXC 1999
- Country
- RYAM United States
- CDXC United States
- Employees
- RYAM N/A
- CDXC N/A
- Industry
- RYAM Paper
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- RYAM Basic Materials
- CDXC Health Care
- Exchange
- RYAM Nasdaq
- CDXC Nasdaq
- Market Cap
- RYAM 495.7M
- CDXC 449.5M
- IPO Year
- RYAM N/A
- CDXC N/A
- Fundamental
- Price
- RYAM $7.39
- CDXC $5.42
- Analyst Decision
- RYAM Buy
- CDXC Strong Buy
- Analyst Count
- RYAM 1
- CDXC 2
- Target Price
- RYAM $12.00
- CDXC $8.00
- AVG Volume (30 Days)
- RYAM 383.7K
- CDXC 338.3K
- Earning Date
- RYAM 03-05-2025
- CDXC 03-05-2025
- Dividend Yield
- RYAM N/A
- CDXC N/A
- EPS Growth
- RYAM N/A
- CDXC N/A
- EPS
- RYAM N/A
- CDXC 0.02
- Revenue
- RYAM $1,630,290,000.00
- CDXC $91,668,000.00
- Revenue This Year
- RYAM $0.83
- CDXC $18.64
- Revenue Next Year
- RYAM $4.22
- CDXC $20.72
- P/E Ratio
- RYAM N/A
- CDXC $275.46
- Revenue Growth
- RYAM N/A
- CDXC 9.95
- 52 Week Low
- RYAM $3.15
- CDXC $1.48
- 52 Week High
- RYAM $10.28
- CDXC $7.97
- Technical
- Relative Strength Index (RSI)
- RYAM 45.95
- CDXC 41.57
- Support Level
- RYAM $6.93
- CDXC $5.38
- Resistance Level
- RYAM $7.41
- CDXC $6.06
- Average True Range (ATR)
- RYAM 0.30
- CDXC 0.22
- MACD
- RYAM -0.01
- CDXC 0.00
- Stochastic Oscillator
- RYAM 28.98
- CDXC 5.88
About RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.